# CMT02_PT default variant is produced correctly

    Code
      res
    Output
                                                              Placebo     Xanomeline High Dose   Xanomeline Low Dose   All Patients
      Other Treatment                                          (N=86)            (N=72)                (N=96)            (N=254)   
      —————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
      Total number of patients with at least one treatment   76 (88.4%)        63 (87.5%)            81 (84.4%)        220 (86.6%) 
      Total number of treatments                                840               656                    736               2232    
      UNCODED                                                72 (83.7%)        62 (86.1%)            79 (82.3%)        213 (83.9%) 
      ACETYLSALICYLIC ACID                                   21 (24.4%)         5 (6.9%)              9 (9.4%)          35 (13.8%) 
      ESTROGENS CONJUGATED                                    6 (7.0%)          4 (5.6%)              9 (9.4%)          19 (7.5%)  
      CALCIUM                                                 7 (8.1%)          3 (4.2%)              5 (5.2%)          15 (5.9%)  
      HYDROCORTISONE                                          1 (1.2%)          4 (5.6%)             10 (10.4%)         15 (5.9%)  
      AMLODIPINE                                              6 (7.0%)          2 (2.8%)              1 (1.0%)           9 (3.5%)  
      DIGOXIN                                                    0              1 (1.4%)              3 (3.1%)           4 (1.6%)  
      DOXAZOSIN MESILATE                                      1 (1.2%)          1 (1.4%)              2 (2.1%)           4 (1.6%)  
      FUROSEMIDE                                              1 (1.2%)          1 (1.4%)              2 (2.1%)           4 (1.6%)  
      NAPROXEN SODIUM                                         1 (1.2%)          3 (4.2%)                  0              4 (1.6%)  
      NIZATIDINE                                              1 (1.2%)          3 (4.2%)                  0              4 (1.6%)  
      ALGELDRATE                                              1 (1.2%)          2 (2.8%)                  0              3 (1.2%)  
      DONEPEZIL HYDROCHLORIDE                                 1 (1.2%)          2 (2.8%)                  0              3 (1.2%)  
      FLUVASTATIN                                                0                 0                  2 (2.1%)           2 (0.8%)  
      LOPERAMIDE HYDROCHLORIDE                                1 (1.2%)             0                  1 (1.0%)           2 (0.8%)  
      METFORMIN HYDROCHLORIDE                                 1 (1.2%)             0                  1 (1.0%)           2 (0.8%)  
      SALBUTAMOL SULFATE                                      2 (2.3%)             0                      0              2 (0.8%)  
      SIMETICONE                                                 0                 0                  2 (2.1%)           2 (0.8%)  
      ALPRAZOLAM                                              1 (1.2%)             0                      0              1 (0.4%)  
      BUDESONIDE                                                 0              1 (1.4%)                  0              1 (0.4%)  
      CALCIUM CARBONATE                                          0              1 (1.4%)                  0              1 (0.4%)  
      FELODIPINE                                                 0                 0                  1 (1.0%)           1 (0.4%)  
      FERROUS SULFATE                                            0                 0                  1 (1.0%)           1 (0.4%)  
      HALOPERIDOL                                                0                 0                  1 (1.0%)           1 (0.4%)  
      IPRATROPIUM BROMIDE                                     1 (1.2%)             0                      0              1 (0.4%)  
      LEUPRORELIN ACETATE                                     1 (1.2%)             0                      0              1 (0.4%)  
      LOSARTAN POTASSIUM                                         0                 0                  1 (1.0%)           1 (0.4%)  
      NIFEDIPINE                                              1 (1.2%)             0                      0              1 (0.4%)  
      SUMATRIPTAN                                             1 (1.2%)             0                      0              1 (0.4%)  

